Home / Stocks / NTLA

NTLA insider trading

Intellia Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
2
Bought · 24 mo
$2.4M
Buys · last 90 days
0 · $0
Most recent buy
2026-01-07

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-01-07Cohen Fred E
Director
Bought150,000$9.35$1.4M
2025-08-22CHASE WILLIAM J
Director
Bought100,000$10.03$1.0M

Most active insider buyers

InsiderRoleBuysTotal bought
Cohen Fred EDirector1$1.4M
CHASE WILLIAM JDirector1$1.0M

See NTLA on the chart

Every insider buy and sell for NTLA plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.